Assignee
LXR BIOTECHNOLOGY INC
US·17 granted patents·337 citations·filing 1993–1997
Top patents by PatentIndex Score
17 records- 0194US5635187ACompositions which inhibit apoptosis, methods of purifying the compositions and uses thereofLXR BIOTECHNOLOGY INC·Filed 1995·Granted Jun 3, 1997·81 cites·2 claims
- 0289US6004579ACompositions which inhibit apoptosis, methods of making the compositions and uses thereofLXR BIOTECHNOLOGY INC·Filed 1996·Granted Dec 21, 1999·94 cites·46 claims
- 0376US5759548ACompositions which inhibit apoptosis, methods of purifying the compositions and uses thereofLXR BIOTECHNOLOGY INC·Filed 1994·Granted Jun 2, 1998·18 cites·16 claims
- 0476US5624672ACompositions which inhibit apoptosis, methods of purifying the compositions and uses thereofLXR BIOTECHNOLOGY INC·Filed 1994·Granted Apr 29, 1997·18 cites·54 claims
- 0567US5652210ASoluble splice variant of the Fas (APO-1) antigen, FasΔTMLXR BIOTECHNOLOGY INC·Filed 1995·Granted Jul 29, 1997·23 cites·6 claims
- 0663US5663070ARecombinant production of a soluble splice variant of the Fas (Apo-1) antigen, fas TMLXR BIOTECHNOLOGY INC·Filed 1993·Granted Sep 2, 1997·15 cites·8 claims
- 0762US6306398B1Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereofLXR BIOTECHNOLOGY INC·Filed 1997·Granted Oct 23, 2001·10 cites·36 claims
- 0861US5770443AApoptosis-modulating proteins, DNA encoding the proteins and methods of use thereofLXR BIOTECHNOLOGY INC·Filed 1995·Granted Jun 23, 1998·9 cites·30 claims
- 0960US5681703AMethods of identifying potentially therapeutically effective agents and cell strains for use thereinLXR BIOTECHNOLOGY INC·Filed 1995·Granted Oct 28, 1997·19 cites·16 claims
- 1056US5635186ACompositions which inhibit apoptosis, methods of purifying the compositions and uses thereofLXR BIOTECHNOLOGY INC·Filed 1995·Granted Jun 3, 1997·7 cites·8 claims
- 1154US6015687AApoptosis-modulating proteins, DNA encoding the proteins and methods of use thereofLXR BIOTECHNOLOGY INC·Filed 1995·Granted Jan 18, 2000·6 cites·1 claims
- 1252US5620885ACompositions which inhibit apoptosis, methods of purifying the compositions and uses thereofLXR BIOTECHNOLOGY INC·Filed 1995·Granted Apr 15, 1997·5 cites·7 claims
- 1349US5567425ACompositions which inhibit apoptosis, methods of purifying the compositions and uses thereofLXR BIOTECHNOLOGY INC·Filed 1995·Granted Oct 22, 1996·4 cites·5 claims
- 1445US5998131AScreening methods for the identification of compounds capable of abrogating BaK-BHRF-1 protein interactionsLXR BIOTECHNOLOGY INC·Filed 1997·Granted Dec 7, 1999·10 cites·6 claims
- 1541US5750360AMethod for quantitatively measuring apoptosisLXR BIOTECHNOLOGY INC·Filed 1995·Granted May 12, 1998·9 cites·15 claims
- 1636US5620888ACell strains for use in identifying potentially therapeutically effective agentsLXR BIOTECHNOLOGY INC·Filed 1995·Granted Apr 15, 1997·5 cites·1 claims
- 1735US5637486AMethods of identifying potentially therapeutically effective agents and cell strains for use thereinLXR BIOTECHNOLOGY INC·Filed 1994·Granted Jun 10, 1997·4 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when LXR BIOTECHNOLOGY INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →